Comparing outcomes of adjunctive treatment in depression: Aripiprazole versus Bupropion

Aripiprazole and bupropion were comparable in significantly lowering patients' QIDS SR16 scores and helping over 50% of the patients achieve remission. Differences in line-item QIDS score were also observed.